Effective "activated PI3K delta syndrome"-targeted therapy with the PI3Kd inhibitor leniolisib

VK Rao; S Webster; V.A.S.H. Dalm; A Sediva; P.M. van Hagen; S Holland; SD Rosenzweig; AD Christ; B Sloth; M Cabanski; AD Joshi; S de Buck; J Doucet; D Guerini; C Kalis; I Pylvaenaeinen; N Soldermann; A Kashyap; G Uzel; MJ Lenardo; DD Patel; CL Lucas; C Burkhart

doi:10.1182/blood-2017-08-801191

Effective "activated PI3K delta syndrome"-targeted therapy with the PI3Kd inhibitor leniolisib

VK Rao, S Webster, V.A.S.H. Dalm, A Sediva, P.M. van Hagen, S Holland, SD Rosenzweig, AD Christ, B Sloth, M Cabanski, AD Joshi, S de Buck, J Doucet, D Guerini, C Kalis, I Pylvaenaeinen, N Soldermann, A Kashyap, G Uzel, MJ LenardoDD Patel, CL Lucas, C Burkhart

Research output: Contribution to journal › Article › Academic › peer-review

148 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2307-2316
Number of pages	10
Journal	Blood
Volume	130
Issue number	21
DOIs	https://doi.org/10.1182/blood-2017-08-801191
Publication status	Published - 2017

Access to Document

10.1182/blood-2017-08-801191

http://hdl.handle.net/1765/103086

Cite this

Rao, VK., Webster, S., Dalm, V. A. S. H., Sediva, A., van Hagen, P. M., Holland, S., Rosenzweig, SD., Christ, AD., Sloth, B., Cabanski, M., Joshi, AD., de Buck, S., Doucet, J., Guerini, D., Kalis, C., Pylvaenaeinen, I., Soldermann, N., Kashyap, A., Uzel, G., ... Burkhart, C. (2017). Effective "activated PI3K delta syndrome"-targeted therapy with the PI3Kd inhibitor leniolisib. Blood, 130(21), 2307-2316. https://doi.org/10.1182/blood-2017-08-801191

@article{16396c6a65bf48e88924c5cf345cf498,

title = "Effective {"}activated PI3K delta syndrome{"}-targeted therapy with the PI3Kd inhibitor leniolisib",

author = "VK Rao and S Webster and V.A.S.H. Dalm and A Sediva and {van Hagen}, P.M. and S Holland and SD Rosenzweig and AD Christ and B Sloth and M Cabanski and AD Joshi and {de Buck}, S and J Doucet and D Guerini and C Kalis and I Pylvaenaeinen and N Soldermann and A Kashyap and G Uzel and MJ Lenardo and DD Patel and CL Lucas and C Burkhart",

year = "2017",

doi = "10.1182/blood-2017-08-801191",

language = "Undefined/Unknown",

volume = "130",

pages = "2307--2316",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "21",

}

Rao, VK, Webster, S, Dalm, VASH, Sediva, A, van Hagen, PM, Holland, S, Rosenzweig, SD, Christ, AD, Sloth, B, Cabanski, M, Joshi, AD, de Buck, S, Doucet, J, Guerini, D, Kalis, C, Pylvaenaeinen, I, Soldermann, N, Kashyap, A, Uzel, G, Lenardo, MJ, Patel, DD, Lucas, CL & Burkhart, C 2017, 'Effective "activated PI3K delta syndrome"-targeted therapy with the PI3Kd inhibitor leniolisib', Blood, vol. 130, no. 21, pp. 2307-2316. https://doi.org/10.1182/blood-2017-08-801191

TY - JOUR

T1 - Effective "activated PI3K delta syndrome"-targeted therapy with the PI3Kd inhibitor leniolisib

AU - Rao, VK

AU - Webster, S

AU - Dalm, V.A.S.H.

AU - Sediva, A

AU - van Hagen, P.M.

AU - Holland, S

AU - Rosenzweig, SD

AU - Christ, AD

AU - Sloth, B

AU - Cabanski, M

AU - Joshi, AD

AU - de Buck, S

AU - Doucet, J

AU - Guerini, D

AU - Kalis, C

AU - Pylvaenaeinen, I

AU - Soldermann, N

AU - Kashyap, A

AU - Uzel, G

AU - Lenardo, MJ

AU - Patel, DD

AU - Lucas, CL

AU - Burkhart, C

PY - 2017

Y1 - 2017

U2 - 10.1182/blood-2017-08-801191

DO - 10.1182/blood-2017-08-801191

M3 - Article

VL - 130

SP - 2307

EP - 2316

JO - Blood

JF - Blood

SN - 0006-4971

IS - 21

ER -